Satya Surbhi

Assistant Professor
Center for Health System Improvement
Medicine-Gen Internal Med

MEMPHIS TN 381632116
Tel: (901) 448-4166


  • Ph.D., University of Tennessee Health Science Center (UTHSC), Memphis, Health Outcomes and Policy Research
  • M.S., St. John’s University, Queens, NY, Pharmacy Administration
  • B.S., Manipal University, India, Bachelor of Pharmacy

Research Interest/Specialty

My research interests focus on improving quality of care and reducing health care costs, particularly for vulnerable low-income individuals. Some of my current research projects include improving medication adherence by providing full subsidy and direct delivery of essential medications, examining racial, income, and geographic disparities in access to primary care and associated health care utilization, and opioid prescribing behavior and health care utilization among medically-complex super-utilizers.

My Current CV


  1. Surbhi, S, Graetz, I, Wan, JY, Gatwood, J, Bailey, JE. The Effect of Opioid Use and Mental Illness on Chronic Disease Medication Adherence in Superutilizers. J Manag Care Spec Pharm, 24 (3), 198-207, 2018.
  2. Nault Connors, JD, Binkley, BL, Graff, JC, Surbhi, S, Bailey, JE. How patient experience informed the SafeMed Program: Lessons learned during a Health Care Innovation Award to improve care for super-utilizers. Healthc (Amst), 2018.
  3. Jamison, JJ, Wang, J, Surbhi, S, Adams, S, Solomon, D, Hohmeier, KC, McDonough, S, Eoff, JC. Impact of Medicare Part D on Racial and Ethnic Minorities. Divers Equal Health Care, 13 (5), 326-333, 2016.
  4. Surbhi, S, Munshi, KD, Bell, PC, Bailey, JE. Drug therapy problems and medication discrepancies during care transitions in super-utilizers. J Am Pharm Assoc (2003), 56 (6), 633-642.e1, 2016.
  5. Bailey, JE, Surbhi, S, Bell, PC, Jones, AM, Rashed, S, Ugwueke, MO. SafeMed: Using pharmacy technicians in a novel role as community health workers to improve transitions of care. J Am Pharm Assoc (2003), 56 (1), 73-81, 2016.
  6. Wang, J, Surbhi, S, Kuhle, JW. Receipt of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers among Medicare Beneficiaries with Diabetes and Hypertension. J Pharm Health Serv Res, 5 (1), 67-74, 2014.
  7. Wang J, Surbhi S, Zhang Z, Spivey CA, Burns MC. Historical trend of racial and ethnic disparities in meeting Medicare medication therapy management eligibility in non-Medicare population.. Res Social Adm Pharm., 2014.